Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.160
+0.570 (15.88%)
At close: Feb 27, 2026, 4:00 PM EST
4.140
-0.020 (-0.48%)
After-hours: Feb 27, 2026, 7:57 PM EST
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $286.89 million as of February 27, 2026. Its market cap has increased by 704.24% in one year.
Market Cap
286.89M
Enterprise Value
257.14M
1-Year Change
704.24%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $286.89M, an increase of 1,249.28%. That is a compound annual growth rate of 63.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 247.58M | 78.61% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 300.78M |
| Cellectis | 294.41M |
| Adlai Nortye | 290.04M |
| Fennec Pharmaceuticals | 289.96M |
| AC Immune | 289.90M |
| Puma Biotechnology | 287.23M |
| Minerva Neurosciences | 285.61M |
| Inhibikase Therapeutics | 280.40M |